TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 0.0300nM ΔG°: -62.5kJ/molepH: 6.2 T: 2°CAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 0.0900nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 0.0900nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 0.110nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 0.170nM ΔG°: -58.0kJ/molepH: 6.2 T: 2°CAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 0.430nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 1.10nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 18.4nM ΔG°: -45.9kJ/molepH: 6.2 T: 2°CAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 25nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 31nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataKi: 160nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.160nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.160nMAssay Description:In vitro inhibitory activity against monkey plasma reninMore data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.230nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.270nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.280nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.350nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.360nMAssay Description:In vitro inhibitory activity against monkey plasma reninMore data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.360nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.370nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in monkeyMore data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.420nMAssay Description:In vitro inhibitory activity against monkey plasma reninMore data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.480nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.540nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.570nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.581nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.590nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.760nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.830nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 0.910nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 1nMpH: 6.2 T: 2°CAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
Target3-hydroxy-3-methylglutaryl-coenzyme A reductase(Rattus norvegicus (rat))
Pfizer
Curated by ChEMBL
Pfizer
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of rat microsomal HMGCoA reductaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 1.10nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 1.40nMpH: 6.2 T: 2°CAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
Target3-hydroxy-3-methylglutaryl-coenzyme A reductase(Rattus norvegicus (rat))
Pfizer
Curated by ChEMBL
Pfizer
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Inhibition of rat microsomal HMGCoA reductaseMore data for this Ligand-Target Pair
Target3-hydroxy-3-methylglutaryl-coenzyme A reductase(Rattus norvegicus (rat))
Pfizer
Curated by ChEMBL
Pfizer
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of rat microsomal HMGCoA reductaseMore data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in monkeyMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 2.20nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 2.20nMpH: 6.2 T: 2°CAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 2.30nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 2.5nMpH: 6.2 T: 2°CAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 2.5nMpH: 6.2 T: 2°CAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 2.60nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 2.60nMpH: 6.2 T: 2°CAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
Target3-hydroxy-3-methylglutaryl-coenzyme A reductase(Rattus norvegicus (rat))
Pfizer
Curated by ChEMBL
Pfizer
Curated by ChEMBL
Affinity DataIC50: 2.60nMAssay Description:Inhibition of rat microsomal HMGCoA reductaseMore data for this Ligand-Target Pair
Target3-hydroxy-3-methylglutaryl-coenzyme A reductase(Rattus norvegicus (rat))
Pfizer
Curated by ChEMBL
Pfizer
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:Inhibition of rat microsomal HMGCoA reductaseMore data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:In vitro inhibitory activity against monkey plasma reninMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Parke-Davis Pharmaceutical Research
Parke-Davis Pharmaceutical Research
Affinity DataIC50: 2.70nMAssay Description:For determination of IC50 values, HIV-1 protease was added to assay buffer containing inhibitor and the substrate (H-His-Lys-Ala-Arg-Val-Leu- (p-NO2)...More data for this Ligand-Target Pair
TargetRenin(Homo sapiens (Human))
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair